Jim Cramer told his television audience to buy Amprius Technologies during a rapid-fire lightning round, offering a standard, surface-level nod to the company's high-energy battery technology. That quick endorsement misses the real story unfolding inside the company. Amprius is undergoing a massive, high-stakes operational transformation that alters its entire financial risk profile. The company recently killed its plans for a massive, dedicated factory in Brighton, Colorado, paying a $20 million termination fee to escape a $110 million long-term lease obligation. Instead of building expensive factories, Amprius is shifting entirely to a capital-light contract manufacturing strategy to survive the brutal capital demands of the battery industry.
For years, the narrative surrounding next-generation lithium-ion batteries focused almost entirely on chemistry. The company that could successfully substitute graphite anodes with pure silicon would win the market. Silicon holds up to ten times more lithium ions by weight than graphite, offering the potential to double the flight times of drones and high-altitude pseudo-satellites.
The physics worked in the lab. Turning that physics into a profitable, high-volume industrial product remains an entirely different battle.
The Silicon Swell and the Lab Trap
Standard lithium-ion batteries rely on graphite anodes to hold lithium ions during charging. When engineers attempt to replace that graphite with silicon to boost energy density, they immediately encounter a fundamental law of materials science. Silicon expands by roughly 300 percent when fully charged. This dramatic swelling causes standard bulk silicon structures to fracture, pulverize, and fail completely after just a few charge cycles.
Amprius solved this specific physical barrier by growing silicon directly as nanowires on a substrate. The microscopic gaps between these nanowires give the silicon room to expand and contract without destroying the cell structure. This design allows their advanced lab cells to achieve energy densities of up to 500 watt-hours per kilogram, nearly double the capacity of standard commercial batteries.
Performance in a controlled research facility does not equal commercial viability. The machinery required to deposit these pure silicon nanowires relies on chemical vapor deposition processes borrowed from the semiconductor industry. It is slow. It is incredibly capital-intensive.
The financial reality of building a massive factory from scratch to house these machines has broken dozens of clean-technology startups over the past decade. Amprius realized it was heading down that exact same cash-burning path before pulling the emergency brake.
The Eighty Million Dollar Retreat from Colorado
The transition from a technology developer to an industrial manufacturer is where hardware companies go to die. Amprius initially planned to build out an 774,000-square-foot gigafactory in Brighton, Colorado, aiming to scale up domestic production. The sheer cost of equipping and maintaining a facility of that size threatened to dilute shareholders and exhaust the company's cash reserves long before the factory turned a profit.
Management reversed course completely. The company terminated the 15-year Colorado lease, absorbing a sharp $20 million exit penalty. Alongside this structural retreat, longtime chief executive Dr. Kang Sun retired, handing the reins to Tom Stepien to oversee a completely restructured business model.
This was a corporate survival move. By abandoning the factory, Amprius wiped more than $110 million in future lease obligations off its balance sheet, pivoting to an asset-light operational strategy.
Instead of pouring hundreds of millions of dollars into concrete and heavy machinery, the company is outsourcing its manufacturing to external partners who already possess underutilized factory footprint.
The strategy showed immediate results in the financial statements. Annual revenue for 2025 surged over 200 percent to $73.0 million, up from $24.2 million the previous year. By avoiding massive factory depreciation costs, gross margins improved by 87 percentage points year-over-year. The momentum carried directly into early 2026, with first-quarter revenues hitting $28.5 million, a 2.5-fold increase over the same period in 2025.
Outsourcing the National Security Supply Chain
Moving away from self-owned manufacturing solves the cash-burn problem, but it introduces deep logistical complications. Military and defense drone sectors make up the core customer base for high-energy silicon batteries. These agencies operate under strict regulatory frameworks. The National Defense Authorization Act bars military entities from purchasing drone components sourced from adversarial supply chains, forcing Amprius to secure trusted domestic assembly lines.
To execute this, Amprius struck a critical contract manufacturing deal with Nanotech Energy. Nanotech operates an operational lithium-ion plant in California, providing Amprius with a domestic, compliant manufacturing footprint without the associated capital expenditures.
The partnership focuses heavily on producing the SA128 silicon-anode cell in a standard 21700 cylindrical format. This cell delivers an energy density of 320 watt-hours per kilogram. While 320 watt-hours per kilogram is significantly lower than the 500 watt-hours per kilogram produced on Amprius' proprietary laboratory lines in Fremont, it represents a stable, reproducible product that can be manufactured at commercial scale today.
The arrangement allowed Amprius to expand its contract with the Pentagon's Defense Innovation Unit by $3.3 million, bringing their total military drone battery contract to $18.1 million. They also landed a $21.0 million purchase order from a light electric vehicle manufacturer, proving that commercial buyers are willing to accept the outsourced, slightly lower-density cells if they can get them reliably and in volume.
The High Stakes Accounting of an Asset Light Future
Wall Street has responded favorably to this operational shift, but the financial tightrope remains exceptionally thin. Amprius has raised its full-year 2026 revenue guidance to at least $130 million. The company projects it will narrow its net loss to under $8.0 million and achieve a positive adjusted EBITDA of at least $4.0 million by the end of the year.
These numbers look promising on a spreadsheet. They hide the vulnerability inherent to any company that does not control its own physical production.
Amprius finished the first quarter of 2026 with $62.4 million in cash and cash equivalents, down from $90.5 million at the close of 2025. That drop reflects the final execution costs of the Colorado termination fee and ongoing working capital needs. With capital expenditures now projected to remain under $10.0 million for the entirety of 2026, the company has successfully stopped its immediate cash bleed.
The remaining risk lies entirely in execution and partner reliability. If Nanotech Energy or their Asian manufacturing partners suffer operational delays, supply bottlenecks, or quality control failures, Amprius has no secondary factories to fall back on. They own the patents, the chemical designs, and the brand, but they are entirely dependent on third-party operational execution to fulfill their growing $130 million revenue backlog.
Retail investors buying into the stock based on a ten-second television recommendation need to understand exactly what they are purchasing. This is no longer a traditional manufacturing company racing to build the biggest factory in America. Amprius is operating as a specialized battery design house, betting that intellectual property and outsourced labor can scale faster than steel and concrete.
